Data as of Apr 17
| -2.02 / -2.06%|
The 14 analysts offering 12-month price forecasts for United Therapeutics Corp have a median target of 101.00, with a high estimate of 150.00 and a low estimate of 68.00. The median estimate represents a +4.99% increase from the last price of 96.20.
The current consensus among 15 polled investment analysts is to Hold stock in United Therapeutics Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.